Expert-Guided Radiopharmaceutical Strategy
We bridge scientific innovation and clinical application with specialized insight to help accelerate radiopharmaceutical development.
Accelerating Radiopharmaceutical Development
Theragnostic Insights was created to solve a critical challenge in radiopharmaceutical development: the gap between scientific discovery and clinical implementation. Too often, promising therapies never reach patients due to misaligned strategy, regulatory complexity, or execution delays.
Led by Dr. Jason Hurt, we deliver the expert guidance needed to move from concept to clinic efficiently. We focus on real-world impact—helping radiopharmaceutical innovators navigate the path to patient access with clarity, speed, and precision.
Committed to Transforming Innovation into Care
We accelerate the clinical implementation of novel radiopharmaceuticals by aligning scientific progress with practical development strategy. Our approach is grounded in clinical excellence, regulatory insight, and a clear focus on patient outcomes.
Accelerating the Future of Precision Medicine
We envision a world where radiopharmaceutical innovations reach patients more efficiently, effectively, and safely. Through our strategic guidance, we aim to remove barriers between scientific advancement and clinical implementation, creating a seamless pathway for these targeted therapies. By fostering collaboration between developers, clinicians, and regulatory experts, we're building a future where precision medicine fulfills its promise of transforming cancer treatment.
.avif)
Principles That Guide Us
01 — Clinical Excellence
We ground all recommendations in deep clinical understanding and maintain the highest standards for patient safety and care.
02 — Strategic Agility
We make decisive, informed decisions that advance projects efficiently without sacrificing quality.
03 — Translatoinal Expertise
We bridge scientific and clinical worlds through specialized knowledge that facilitates understanding across disciplines.
04 — Practical Innovation
We embrace innovative approaches that have clear paths to clinical implementation and patient benefit.
05 — Authentic Partnership
We build relationships based on transparent communication, mutual respect, and shared commitment to advancing treatments.
Bridging Science & Implementation
We connect scientific development with clinical implementation for radiopharmaceutical therapies, providing unique insight across both domains. Our specialized knowledge combines clinical expertise, scientific understanding, and business strategy focused exclusively on radiopharmaceuticals.
Jason D. Hurt, MD, MBA
Dr. Hurt is a physician-executive with deep experience in radiopharmaceutical and oncology drug development. As Chief Medical Officer at Orano Med and Senior Medical Director at Reata Pharmaceuticals, he led the advancement of breakthrough targeted therapies across clinical development and regulatory strategy.
With a clinical background in gynecologic oncology and an MBA from Xavier University, Dr. Hurt brings a rare blend of medical and business acumen. He founded Theragnostic Insights to connect scientific innovation with real-world application, offering clients high-performance strategy rooted in precision, mentorship, and execution excellence.
Precision-Guided Support
We draw on a trusted network of senior experts to deliver precise radiopharmaceutical development support across clinical strategy, regulatory affairs, oncology, and health physics.
With deep oncology expertise and a track record in precision medicine, Dr. Armour has led global development efforts and pioneered radioligand therapies including Pluvicto.
A regulatory strategist with 25+ years in pharma, Alicia bridges sponsors and health authorities, bringing advanced therapies to patients with speed and clarity.
A leader in radiation oncology physics, Dr. Lamba brings decades of experience implementing new radiotherapy technologies and guiding facility development.
Lake is a radiopharma expert with 12 years in isotope production and GMP manufacturing. He’s launched three RLT sites and advises on CMC, safety, and strategy.
Ready to Accelerate Your Radiopharmaceutical Development?
Schedule a consultation to discuss how our specialized expertise can help bridge the gap between your scientific innovation and clinical implementation.
